D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PHAT holding history
Phathom Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAT overviewAll 13F holders of PHATFull Q2 2026 holdings
- Shares (Q2 2026)
- 95,660
- Value
- $1.04M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 95,660 | $1.04M | <0.1% | −36,797−27.8% | Reduced | Holders |
| Q1 2026 | 132,457 | $1.47M | <0.1% | −128,611−49.3% | Reduced | Holders |
| Q4 2025 | 261,068 | $4.33M | <0.1% | +261,068 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −143,707−100.0% | Sold out | Holders |
| Q3 2024 | 143,707 | $2.60M | <0.1% | +143,707 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −64,138−100.0% | Sold out | Holders |
| Q1 2024 | 64,138 | $681.1K | <0.1% | −65,251−50.4% | Reduced | Holders |
| Q4 2023 | 129,389 | $1.18M | <0.1% | −1,175−0.9% | Reduced | Holders |
| Q3 2023 | 130,564 | $1.35M | <0.1% | +16,871+14.8% | Added | Holders |
| Q2 2023 | 113,693 | $1.63M | <0.1% | +113,693 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −14,477−100.0% | Sold out | Holders |
| Q3 2022 | 14,477 | $160.0K | <0.1% | −47,781−76.7% | Reduced | Holders |
| Q2 2022 | 62,258 | $525.0K | <0.1% | +62,258 | New | Holders |